Tango Therapeutics, Inc. is a biotechnology firm dedicated to the research and development of innovative cancer treatments. Their primary therapeutic candidate, TNG908, is a synthetic lethal small molecule designed to inhibit protein arginine…
Sector
Healthcare
Exchange
NASDAQ
Country
US
Tango Therapeutics (TNGX) Key Financials
Charts, filings, and peer comparison for every metric
Income Statement
Balance Sheet
Tango Therapeutics (TNGX) Analysis Tools & Insights
Income Statement